Literature DB >> 25099888

Current practice trends in allergy: results of a united states survey of otolaryngologists, allergist-immunologists, and primary care physicians.

Matthew W Ryan1, Bradley F Marple, Bryan Leatherman, J Whit Mims, John Fornadley, Maria Veling, Sandra Y Lin.   

Abstract

BACKGROUND: Clinical practices for the diagnosis and treatment of allergic disease evolve over time in response to a variety of forces. The techniques used by various physician specialties are not clearly defined and may vary from published descriptions or recommendations in the literature.
METHODS: This work is a Web-based survey enrolling 250 U.S. physicians in the following specialties: otolaryngology (ENT), allergy-immunology (A/I), and primary care (PCP).
RESULTS: Respondents reported that skin-prick testing is the most common diagnostic testing method, followed by in vitro specific immunoglobulin E (IgE) testing. ENTs were more likely to use intradermal testing compared to other specialties (p = 0.0003 vs A/I; p < 0.0001 vs PCP). Respondents reported a wide distribution in number of allergens tested, regardless of testing method (range, 11 to >60). Significant use of home immunotherapy injections (defined as >10% of immunotherapy patients) ranged from 27% to 36% of physicians, with no statistically significant difference noted based upon specialty. PCPs reported greater use of sublingual immunotherapy (PCP, 68%; A/I, 45%; otolaryngology, 35%; A/I vs PCP, p = 0.005; ENT vs PCP p < 0.001)).
CONCLUSION: A variety of allergy testing and treatment methods are employed by U.S. physicians, with some differences noted based upon specialty. Home immunotherapy continues to be employed in allergy practices, and sublingual immunotherapy is a common form of delivery, especially in primary care practices.
© 2014 ARS-AAOA, LLC.

Entities:  

Keywords:  allergen immunotherapy; allergy; allergy testing; food allergy; home immunotherapy; sublingual immunotherapy

Mesh:

Substances:

Year:  2014        PMID: 25099888     DOI: 10.1002/alr.21359

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  2 in total

Review 1.  The Future of Sublingual Immunotherapy in the United States.

Authors:  Nicole Pleskovic; Ashton Bartholow; Deborah A Gentile; David P Skoner
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

2.  Allergic diseases influence symptom severity and T lymphocyte subgroups of children with tic disorders.

Authors:  Xiumei Liu; Xueming Wang; Xiaoling Zhang; Ai Hua Cao
Journal:  J Investig Med       Date:  2021-07-13       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.